Part 11 Comment Period Extension Possible – FDA Safety Officer
This article was originally published in The Tan Sheet
Executive Summary
FDA is considering reopening the comment period on the electronic records and signatures rule and may reschedule a public meeting to discuss changes, according to Consumer Safety Officer George Smith